Jordan E. Ezekian MD, MPH , Charles C. Anderson MD , Peter F. Aziz MD , Samia Baluch MS , Stuart Berger MD , Martha Lopez-Anderson BBA , Vincent Miller MMCI , Yoshihide Mitani MD, PhD , Silvana Molossi MD, PhD , Valarie Morrow MD , Victoria L. Vetter MD, MPH , Elizabeth Vickers Saarel MD , Bhavya Trivedi MD, PhD , Salim F. Idriss MD PhD , 2024 Think Tank participants
{"title":"The 2024 think tank on prevention of sudden cardiac death in the young: Pathway to survival. A report from the cardiac safety research consortium","authors":"Jordan E. Ezekian MD, MPH , Charles C. Anderson MD , Peter F. Aziz MD , Samia Baluch MS , Stuart Berger MD , Martha Lopez-Anderson BBA , Vincent Miller MMCI , Yoshihide Mitani MD, PhD , Silvana Molossi MD, PhD , Valarie Morrow MD , Victoria L. Vetter MD, MPH , Elizabeth Vickers Saarel MD , Bhavya Trivedi MD, PhD , Salim F. Idriss MD PhD , 2024 Think Tank participants","doi":"10.1016/j.ahj.2025.03.010","DOIUrl":null,"url":null,"abstract":"<div><div>Sudden cardiac arrest and death in the young is a critical public health issue. It occurs in children of any age, sex, racial or ethnic demographic, or socioeconomic status. Importantly, it can affect any individual—athlete and nonathlete alike. Prevention of sudden death in the young is of high importance not only because of the loss of a young life but also because of the substantial impact to families and to society at large. This White Paper summarizes the proceedings of a third national Think Tank on prevention of sudden cardiac death in the young. The Think Tank, which convened on January 11 to 12, 2024 at Duke University in Durham, NC, was organized and conducted by the Cardiac Safety Research Consortium in collaboration with a broad panel of US and international stakeholders including representatives from the United States Food and Drug Administration, medicine, academia, industry, the military, parents and sudden cardiac arrest/death prevention advocates, and the public. Primary and secondary prevention of sudden cardiac death in youth were discussed in depth with a goal of developing consensus on uniform approaches which could be applied nationally.</div></div>","PeriodicalId":7868,"journal":{"name":"American heart journal","volume":"286 ","pages":"Pages 45-55"},"PeriodicalIF":3.7000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American heart journal","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002870325000924","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Sudden cardiac arrest and death in the young is a critical public health issue. It occurs in children of any age, sex, racial or ethnic demographic, or socioeconomic status. Importantly, it can affect any individual—athlete and nonathlete alike. Prevention of sudden death in the young is of high importance not only because of the loss of a young life but also because of the substantial impact to families and to society at large. This White Paper summarizes the proceedings of a third national Think Tank on prevention of sudden cardiac death in the young. The Think Tank, which convened on January 11 to 12, 2024 at Duke University in Durham, NC, was organized and conducted by the Cardiac Safety Research Consortium in collaboration with a broad panel of US and international stakeholders including representatives from the United States Food and Drug Administration, medicine, academia, industry, the military, parents and sudden cardiac arrest/death prevention advocates, and the public. Primary and secondary prevention of sudden cardiac death in youth were discussed in depth with a goal of developing consensus on uniform approaches which could be applied nationally.
期刊介绍:
The American Heart Journal will consider for publication suitable articles on topics pertaining to the broad discipline of cardiovascular disease. Our goal is to provide the reader primary investigation, scholarly review, and opinion concerning the practice of cardiovascular medicine. We especially encourage submission of 3 types of reports that are not frequently seen in cardiovascular journals: negative clinical studies, reports on study designs, and studies involving the organization of medical care. The Journal does not accept individual case reports or original articles involving bench laboratory or animal research.